{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-076186","form_type":"8-K","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.172609+00:00","generated_at":"2026-06-01T02:56:15.814829+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Galecto shareholders approve reverse stock split and elect Anne Prener to board","bullets":["Director Anne Prener elected with 10,651,770 for, 711,618 withheld; 5,840,793 broker non-votes.","Reverse stock split approved (ratio 1:4 to 1:25, board to decide within one year): 15,283,182 for, 1,830,713 against.","Ratification of EY as auditor for FY2024 passed with 16,927,703 for, 197,148 against.","Total shares entitled to vote: 27,112,697; 17,204,181 present or represented."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-076186","json":"https://secwatch.observer/filing/0000950170-24-076186.json","markdown":"https://secwatch.observer/filing/0000950170-24-076186.md","text":"https://secwatch.observer/filing/0000950170-24-076186.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024076186/0000950170-24-076186-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024076186/glto-20240620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:56:15.814829+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}